Abstract
New 3-aryl-pyrido[2,1-b][1,3]benzothiazole derivatives 2a–e were synthesized in excellent yields via the reaction of benzothiazoleacetonitrile (1) with different aromatic aldehydes. The treatment of 2-(benzo[d]thiazol-2-yl)-3-(pyridin-4-yl)acrylonitrile (6) with malononitrile afforded 1-amino-3-(pyridin-4-yl)-3H-pyrido[2,1-b][1,3]benzothiazole-2,4-dicarbonitrile (7), which was allowed to react with a variety of reagents to provide pyrimido[5′,4′:5,6]pyrido[2,1-b][1,3]benzothiazole 8, 9 and [1,3]benzothiazolo[3,2-a][1,8]naphthyridine 10, 15 derivatives. All synthesized products were confirmed by elemental analysis, IR, 1H-NMR, 13C-NMR, and mass spectral data.
Introduction
Benzothiazole derivatives have been important heterocycles for many years because of their broad bioactivities, including antimicrobial [1–5], anticancer [6–11], anthelmintic [12], anticonvulsant [13], and antidiabetic [14] activities. They also serve as intermediates for dyes [15]. In addition, some fused pyridopyrimidine derivatives are biologically active [16–18].
In a similar way, 1,8-naphthyridine derivatives have received attention recently, primarily because this ring system is present in many compounds isolated from natural sources. They exhibit various biological activities [19], such as antibacterial [20, 21], antitumor [22], and antiplatelet [23, 24] activities. Furthermore, various substituted benzothiazoles such as 2-aryl benzothiazoles have received much attention because of their unique structures and uses as radioactive amyloid imagining agents [25] and anticancer agents [26]. In continuation of our interest in the synthesis of heterocycles containing a benzothiazole moiety [27–30], we report herein a facile route to several new benzothiazole-fused heterocyclic systems. We present efficient synthesis of novel pyrido[2,1-b][1,3]benzothiazole, pyrimidopyrido[2,1-b][1,3]benzothiazole, and benzothiazolo[3,2-a][1,8] naphthyridine derivatives.
Results and discussion
As shown in Scheme 1, condensation of compound 1 with benzaldehyde, furfural, 5-bromo-1H-indole-3-carbaldehyde, piperonal, or 4-hydroxy-2-methoxybenzaldehyde in refluxing THF containing a catalytic amount of TEA furnished the corresponding 1-amino-3-aryl-2-(2-benzothiazolyl)-3H-pyrido[2,1-b][1,3]benzothiazole-4-carbonitrile derivatives 2a–e. The assignments of structures 2a–e were supported by their elemental analyses and spectral data. The 1H NMR spectra of structures 2a–e show two singlets at δ 4.60–4.82 and 8.10–8.90 ppm for C3-H and NH2 protons, respectively. In addition, the 1H-NMR spectrum of compound 2c shows a singlet at δ 10.95 ppm assignable to the NH proton of the indole group. Also, compound 2d showed a signal at δ 6.10 ppm assignable to the methylene group. Compound 2e exhibits singlets at δ 3.80 and 10.10 assignable to the OMe and OH protons, respectively. Mass spectra of 2a–e contain the molecular ion peak for each compound.

In contrast to the above-mentioned reaction, the treatment of compound 1 with 1,5-diphenyl-1H-pyrazole-3-carbaldehyde (3) in THF in the presence of a catalytic amount of TEA furnished 2-(benzo[d]thiazol-2-yl)- 3-(1,5-diphenyl-1H-pyrazol-3-yl)acrylonitrile (4) rather than the expected product 5 (Scheme 2). The IR spectrum of 4 shows the absence of NH2 absorption band, but the absorption band at 2198 cm-1 corresponding to a CN group is seen clearly. The structure of 4 is consistent with the 1H NMR spectrum, which shows the absence of any D2O exchangeable signal. There is a precedence in the literature for this outcome, in which the condensation between 1 and isonicotinaldehyde in boiling THF containing a catalytic amount of TEA afforded the (E)-2-(benzo[d]thiazol-2-yl)-3-(pyridin-4-yl)acrylonitrile (6) [31] (Scheme 3). Heating under reflux of compound 6 with malononitrile in ethanol in the presence of a catalytic amount of TEA afforded 1-amino-3-(pyridin-4-yl)-3H-pyrido[2,1-b][1,3]benzothiazole-2,4-dicarbonitrile (7) [32] (Scheme 4). The IR spectrum of 7 displays stretching vibration bands at 3363, 3243, 2208, and 2191 cm-1 corresponding to NH2 and two CN groups, respectively. Its 1H NMR spectrum reveals the presence of signals at δ 4.71 and 6.52 ppm assignable to the C3-H and NH2 protons, respectively. The mass spectrum shows the molecular ion peak at m/z 329 (M+, 49%), corresponding to the molecular formula C18H11N5S.



Compound 7 was utilized as a starting material for preparation of a wide variety of fused heterocyclic compounds. Thus, heating of compound 7 with formamide afforded 4-amino-5-(pyridin-4-yl)-5H-pyrimido[5′,4′:5,6]pyrido[2,1-b][1,3]benzothiazole-6-carbonitrile (8). Similarly, a cyclocondensation of compound 7 with hot formic acid afforded 4-oxo-5-(pyridin-4-yl)-3,5-dihydropyrimido[5′,4′:5,6]pyrido[2,1-b][1,3]benzothiazole-6-carbonitrile (9) (Scheme 5). The IR spectrum of compound 9 displays stretching vibration bands at 3284, 2195, and 1645 cm-1 corresponding to NH, CN, and C=O groups, respectively. Its 1H NMR spectrum reveals the presence of three singlet signals at δ 4.71, 8.68, and 11.23 ppm assignable to the respective protons C5-H, C2-H, and NH protons. The mass spectrum shows the molecular ion peak at m/z 357 (M+, 25%) corresponding to the molecular formula C19H11N5OS. Compound 9 is apparently formed by partial nitrile hydrolysis, amine formylation, and cyclodehydration.

Compound 7 can be transformed into a number of derivatives. For example, heating compound 7 with malononitrile in DMF and a catalytic amount of TEA under reflux conditions afforded 2,4-diamino-5-(pyridin-4-yl)-5H-[1,3]benzothiazolo[3,2-a][1,8]naphthyridine-3,6-dicarbonitrile (10) rather than the analog 11, in line with the reported results [33] (Scheme 6). The IR spectrum of compound 10 shows the presence of signals for two NH2 groups around 3405–3313 cm-1 and two cyano groups at 2205 and 2199 cm-1. The 1H NMR spectrum of compound 10 shows a singlet at δ 4.73 assignable to C5-H, two singlets (D2O exchangeable) at 6.52 and 8.25 ppm assignable to two NH2 groups and no signal in the region of 3–4 ppm for a methylene group. Also, 13C NMR spectrum reveals only one signal in the region of 20–60 ppm because of C5, which is consistent with the given structure 10.

By contrast, the treatment of 7 with ethyl cyanoacetate in boiling DMF containing a catalytic amount of TEA afforded the dicarbonitrile 15 rather than its analog 13 (Scheme 7).

The structure of 15 was confirmed on the basis of IR, 1H NMR, 13C NMR, and MS data. The mass spectrum shows the molecular ion peak at m/z 396 (M+, 100%), which is consistent with the proposed structure, whereas the absence of a triplet-quartet pattern in the 1H NMR spectrum confirms elimination of the ethoxy group during the reaction.
Conclusions
A convenient and efficient one-pot synthesis of substituted pyrido[2,1-b][1,3]benzothiazoles based on reaction of benzothiazoleacetonitrile with different aromatic aldehydes has been developed. Pyrido[2,1-b]benzothiazole derivative 7 was used as a key precursor for synthesis of novel pyrimidopyrido[2,1-b][1,3]benzothiazole and [1,3]benzothiazolo [3,2-a][1,8]naphthyridine derivatives.
Experimental
Melting points were measured with a Gallenkamp apparatus and are uncorrected. IR spectra were recorded in KBr discs on a Mattson 5000 FTIR spectrophotometer at Microanalytical Unit, Faculty of Science, Mansoura University. 1H NMR (300 MHz) and 13C NMR (75 MHz) spectra were measured on Bruker WP AC 300 instrument in DMSO-d6. Electron-impact mass spectra were determined on Finnigan Incos 500 at 70 eV. Elemental analyses were carried out at the Microanalytical Centre, Faculty of Science, Cairo University.
General procedure for the synthesis of 1-amino-3-aryl-2-(2-benzothiazolyl)-3H-pyrido[2,1-b][1,3]benzothiazole-4-carbonitriles 2a–e
A mixture of 2-cyanomethylbenzothiazole (1, 1.74 g, 0.01 mol), an aromatic aldehyde (0.005 mol) in THF (15 mL) and Et3N (a few drops), was heated under reflux for 6–8 h (TLC monitored). After cooling, the resultant precipitate was isolated by suction, washed with EtOH (5 mL), and then crystallized from THF/EtOH (1:1) to afford compound 2a–e.
1-Amino-2-(2-benzothiazolyl)-3-phenyl-3H-pyrido[2,1-b][1,3]benzothiazole-4-carbonitrile (2a)
Yellow crystals; yield 85%; mp 221–223°C; IR: ν 3354, 3321 (NH2), 2195 cm-1 (CN); 1H NMR: δ 4.82 (s, 1H, CH), 7.20–8.10 (m, 13H, Ar-H), 8.40 (s, 2H, NH2); 13C NMR: δ 32.1, 60.5, 86.4, 117.5, 120.1, 121.5 (2C), 122.3 (2C), 124.4 (2C), 126.6 (3C), 127.5 (2C), 128.6 (2C), 136.4, 145.3 (2C), 150.5, 153.3, 160.2, 162.3; MS: m/z 436 (M+, 23%). Anal. Calcd for C25H16N4S2 (436.55): C, 68.78; H, 3.69; N, 12.83. Found: C, 68.72; H, 3.71; N, 12.80.
1-Amino-2-(2-benzothiazolyl)-3-(2-furyl)-3H-pyrido[2,1-b][1,3]benzothiazole-4-carbonitrile (2b)
Yellow crystals; yield 79%; mp 183–185°C; IR: ν 3356, 3330 (NH2), 2198 cm-1 (CN); 1H NMR: δ 4.64 (s, 1H, CH), 6.19 (m, 1H, C4-H of furan), 6.38 (d, 1H, C3-H of furan), 7.20–8.10 (m, 10H, Ar-H), 8.40 (s, 2H, NH2); 13C NMR: δ 27.6, 62.4, 86.5, 108.8, 110.7, 117.5, 120.2, 121.3 (2C), 122.4 (3C), 124.2, 126.5 (2C), 136.4, 140.2, 145.4, 150.5, 152.5, 153.4, 160.2, 162.4; MS: m/z 426 (M+, 56%). Anal. Calcd for C23H14N4OS2 (426.51): C, 64.77; H, 3.31; N, 13.14. Found: C, 67.73; H, 3.33; N, 13.18.
1-Amino-2-(2-benzothiazolyl)-3-(5-bromo-1H-3-indolyl)--3H-pyrido[2,1-b][1,3]benzothiazole-4-carbonitrile (2c)
Yellow crystals; yield 64%; mp>300°C; IR: ν 3387, 3334 (NH2), 3188 (NH), 2200 cm-1 (CN); 1H NMR: δ 4.76 (s, 1H, CH), 7.20–8.10 (m, 12H, Ar-H), 8.90 (s, 2H, NH2), 10.95 (s, 1H, NH); 13C NMR: δ 31.8, 61.5, 86.6, 106.4, 114.4, 116.3, 117.4, 120.2, 121.1 (3C), 122.3 (2C), 124.6 (4C), 126.4 (2C), 130.2, 136.6 (2C), 145.4, 150.2, 153.5, 160.3, 162.2; MS: m/z 554 (M+, 33%). Anal. Calcd for C27H16 BrN5S2 (554.48): C, 58.49; H, 2.91; N, 12.63. Found: C, 58.44; H, 2.89; N, 12.66.
1-Amino-2-(2-benzothiazolyl)-3-(benzo[d][1,3]dioxol-5-yl)-3H-pyrido[2,1-b][1,3] benzothiazole-4-carbonitrile (2d)
Yellow crystals; yield 71%; mp 215–217°C; IR: ν 3410, 3385 (NH2), 2208 cm-1 (CN); 1H NMR: δ 4.60 (s, 1H, CH), 6.10 (s, 2H, CH2), 7.20–8.10 (m, 11H, Ar-H) 8.44 (s, 2H, NH2); 13C NMR: δ 33.3, 61.4, 86.5, 101.4, 110.5, 113.5, 117.6, 120.2, 121.3 (2C), 122.4 (2C), 124.5 (3C), 126.7 (2C), 136.4 (2C), 145.8 (3C), 150.3, 153.8, 160.2, 162.3; MS: m/z 480 (M+, 27%). Anal. Calcd for C26H16 N4O2S2 (480.56): C, 64.98; H, 3.36; N, 11.66. Found: C, 65.01; H, 3.39; N, 11.69.
1-Amino-2-(2-benzothiazolyl)-3-(4-hydroxy-2-methoxyphenyl)-3H-pyrido[2,1-b][1,3] benzothiazole-4-carbonitrile (2e)
Yellow crystals; yield 62%; mp 180–182°C; IR: ν br 3400–3300 (NH2 and OH), 2220 cm-1 (CN); 1H NMR: δ 3.80 (s, 3H, OCH3), 4.60 (s, 1H, CH), 7.20–8.10 (m, 11H, Ar-H), 8.10 (s, 2H, NH2), 10.10 (br s, 1H, OH); 13C NMR: δ 31.5, 56.4, 61.2, 86.4, 102.4, 110.2, 113.6, 117.5, 120.3, 121.3 (2C), 122.5, 124.6 (3C), 126.7 (2C), 131.5, 136.2, 145.6, 150.3, 153.7, 155.8, 159.5, 160.5, 162.3; MS: m/z 482 (M+, 36%). Anal. Calcd for C26H18 N4O2S2 (482.58): C, 64.71; H, 3.76; N, 11.61. Found: C, 64.70; H, 3.79; N, 11.64.
Synthesis of 2-(benzo[d]thiazol-2-yl)-3-(1,5-diphenyl-1H-pyrazol-3-yl)acrylonitrile (4)
A mixture of 2-cyanomethylbenzothiazole (1, 1.74 g, 0.01 mol), 1,5-diphenyl-1H-pyrazole-3-carbaldehyde (3, 2.48 g, 0.01 mol), and Et3N (a few drops) in THF (15 mL) was heated under reflux for 8 h. After cooling, the resultant precipitate was isolated by suction, washed with EtOH (5 mL), and then crystallized from THF/EtOH (1:1) to afford compound 4: Yellow crystals; yield 68%; mp 220–222°C; IR: ν 2198 cm-1 (CN); 1H NMR: δ 7.10–8.20 (m, 14H, Ar-H), 7.19 (s, 1H, C4-H of pyrazole), 8.17 (s, 1H, olefinic); 13C NMR: δ 110.5, 112.5, 117.5, 120.5, 121.4, 122.5, 124.5 (2C), 126.2 (2C), 128.3 (3C), 130.2 (4C), 133.4 (2C), 139.8, 141.2, 143.3, 145.5, 156.5, 162.6; MS: m/z 404 (M+, 35%). Anal. Calcd for C25H16 N4S (404.49): C, 74.24; H, 3.99; N, 13.85. Found: C, 74.28; H, 3.99; N, 13.82.
Synthesis of (E)-2-(benzo[d]thiazol-2-yl)-3-(pyridin-4-yl)acrylonitrile (6)
A solution of compound 1 (1.74 g, 0.01 mol) and isonicotinaldehyde (1.07 g, 0.01 mol) in THF (10 mL) containing three drops of Et3N was heated under reflux for approximately 4 h, with progress monitored by TLC. The solid product 6 formed upon cooling was filtered off, dried, and crystallized from EtOH: Yellow crystals; yield 88%; mp 195–196°C; IR: ν 2215 cm-1 (CN); 1H NMR: δ 7.41 (d, 2H, J = 7.60 Hz, C3-H, C5-H of pyridine), 7.55 (m, 2H, C5-H and C6-H of benzothiazole), 7.95 (dd, 1H, J = 7.40 Hz and 1.50 Hz, C7-H of benzothiazole), 8.20 (s, 1H, vinylic H), 8.23 (dd, 1H, J = 7.50 Hz and 1.50 Hz, C4-H of benzothiazole), 8.66 (d, 2H, J = 7.80 Hz, C2-H, C6-H of pyridine); 13C NMR: δ 113.2, 117.8, 121.4, 122.0, 123.7 (3C), 126.1, 133.3, 144.9 (3C), 152.6, 153.8, 162.2; MS: m/z 263 (M+, 52%). Anal. Calcd for C15H9N3S (263.32): C, 68.42; H, 3.45; N, 15.96. Found C, 68.40; H, 3.49; N, 16.01.
Synthesis of 1-amino-3-(pyridin-4-yl)-3H-pyrido[2,1-b][1,3]benzothiazole-2,4-dicarbonitrile (7)
A mixture of compound 6 (2.62 g, 0.01 mol) and malononitrile (0.66 g, 0.01 mol) in absolute EtOH (10 mL) containing Et3N (3 drops) was heated under reflux for 4 h and then allowed to cool. The precipitated product was filtered off, washed with EtOH, and crystallized from EtOH to afford compound 7: Yellow crystals; yield 95%; mp 263–264°C; IR: ν 3363, 3243 (NH2), 2208 and 2191 (two CN), 1618, 1490 cm-1, aromatic; 1H NMR: δ 4.71 (s, 1H, C3-H), 6.52 (s, 2H, NH2), 7.12 (dd, 1H, J = 7.70 Hz and 1.50 Hz, C4-H of benzothiazole), 7.27 (d, 2H, J = 7.70 Hz, C3-H, C5-H of pyridine), 7.38 (m, 2H, C5-H and C6-H of benzothiazole), 7.70 (dd, 1H, J = 7.50 and 1.50 Hz, C7-H of benzothiazole), 8.59 (d, 2H, J = 7.80 Hz, C2-H, C6-H of pyridine); 13C NMR: δ 30.9, 62.5, 67.8, 117.5 (2C), 120.3, 121.0, 122.8 (3C), 124.4, 126.6, 145.7, 148.5 (2C), 151.2, 162.5, 164.5; MS: m/z 329 (M+, 49%). Anal. Calcd for C18H11N5S (329.38): C, 65.64; H, 3.37; N, 21.26. Found C, 65.69; H, 3.45; N, 21.35.
Synthesis of 4-amino-5-(pyridin-4-yl)-5H-pyrimido[5′,4′:5,6]pyrido[2,1-b][1,3]benzothiazole-6-carbonitrile (8)
A solution of compound 7 (3.29 g, 0.01 mol) in (5 mL) of formamide (0.45 g, 0.01 mol) was refluxed for 12 h, and then allowed to cool. The precipitate that formed was filtered off and crystallized from DMF to give compound 8: Black crystals; yield 29%; mp>350°C; IR: ν 3398, 3312 (NH2) and 2198 cm-1 (CN); 1H NMR: δ 4.76 (s, 1H, C5-H), 6.56 (s, 2H, NH2), 7.15 (dd, 1H, J = 7.40 Hz and 1.50 Hz, C11-H), 7.21 (d, 2H, J = 7.60 Hz, C3-H, C5-H of pyridine), 7.30–7.40 (m, 2H, C9-H and C10-H), 7.81 (dd, 1H, J = 7.50 Hz and 1.50 Hz, C8-H), 7.92 (s, 1H, C2-H), 8.56 (d, 2H, J = 7.80 Hz, C2-H, C6-H of pyridine); 13C NMR: δ 27.2, 61.4, 106.0, 117.8, 120.3, 121.7, 122.8, 124.4 (3C), 126.5, 145.6 (2C), 148.6 (2C), 155.4, 156.5, 162.2, 163.6; MS: m/z 356 (M+, 25%). Anal. Calcd for C19H12N6S (356.41): C, 64.03; H, 3.39; N, 23.58. Found C, 64.12; H, 3.47; N, 23.50.
Synthesis of 4-oxo-5-(pyridin-4-yl)-3,5-dihydro-pyrimido[5′,4′: 5,6]pyrido[2,1-b][1,3]benzothiazole-6-carbonitrile (9)
A mixture of compound 7 (3.29 g, 0.01 mol) and formic acid (15 mL, 88%) was heated under reflux for 16 h and then allowed to cool. The precipitate that formed was filtered off and crystallized from DMF to give compound 9: Pink crystals; yield 35%; mp 320–322°C; IR: ν 3284 (NH), 2195 (CN), and 1645 cm-1 (C=O);1H NMR: δ 4.71 (s, 1H, C5-H), 7.15 (dd, 1H, J = 7.40 Hz and 1.50 Hz, C11-H), 7.21 (d, 2H, J = 7.70 Hz, C3-H, C5-H of pyridine), 7.30–7.40 (m, 2H, C9-H and C10-H), 7.78 (dd, 1H, J = 7.60 Hz and 1.40 Hz, C8-H), 8.56 (d, 2H, J = 7.80 Hz, C2-H, C6-H of pyridine), 8.68 (s, 1H, C2-H), 11.23 (s, 1H, NH); 13C NMR: δ 29.5, 61.7, 102.7, 117.4, 120.2, 121.3, 122.6, 123.6 (3C), 126.5, 145.6, 146.7, 148.5 (2C), 150.4, 153.8, 162.3, 165.3; MS: m/z 357 (M+, 25%). Anal. Calcd for C19H11N5OS (357.39): C, 63.85; H, 3.10; N, 19.60. Found C, 63.80; H, 3.18; N, 19.68.
Synthesis of 2,4-diamino-5-(pyridin-4-yl)-5H-[1,3]benzothiazolo [3,2-a][1,8]naphthyridine-3,6-dicarbonitrile (10)
A mixture of compound 7 (3.29 g, 0.01 mol) and malononitrile (0.66 g, 0.01 mL) in DMF (10 mL) containing a few drops of Et3N was heated under reflux for 8 h and then allowed to cool. The precipitate that formed was filtered off and crystallized from DMF to give compound 10: Black crystals; yield 29%; mp>350°C; IR ν cm-1: 3405–3313 (2 NH2) and 2205, 2199 cm-1 (2 CN); 1H NMR: δ 4.73 (s, 1H, C5-H), 6.52 (s, 2H, NH2), 7.18 (dd, 1H, J = 7.50 Hz and 1.50 Hz, C11-H), 7.23 (d, 2H, J = 7.70 Hz, C3-H, C5-H of pyridine), 7.35–7.48 (m, 2H, C9-H and C10-H), 7.89 (dd, 1H, J = 7.50 Hz and 1.50 Hz, C8-H), 8.25 (s, 2H, NH2), 8.59 (d, 2H, J = 7.70 Hz, C2-H, C6-H of pyridine); 13C NMR: δ 27.0, 58.4, 61.6, 101.4, 115.3, 117.5, 120.3, 121.7, 122.5, 124.4 (3C), 126.5, 145.2, 146.1, 148.4 (2C), 153.9, 162.2 (2C), 163.5; MS: m/z 395 (M+, 100%). Anal. Calcd for C21H13N7S (395.44): C, 63.78; H, 3.31; N, 24.79. Found C, 63.85; H, 3.40; N, 24.70.
Synthesis of 4-amino-2-oxo-5-(pyridin-4-yl)-1,5-dihydro-2H-[1,3]benzothiazolo[3,2-a][1,8]naphthyridine-3,6-dicarbonitrile (15)
A solution of compound 7 (3.29 g, 0.01 mol) in DMF (10 mL) containing ethyl cyanoacetate (1.13 g, 0.01 mL) and Et3N (4 drops) was heated under reflux for 8 h and then allowed to cool. The precipitate that formed was filtered off and crystallized from DMF to give compound 15: Black crystals; yield 29%; mp 195–197°C; IR: ν 3430, 3329 (NH2), 3298 (NH), 2202, 2193 (2CN), and 1644 cm-1 (C=O); 1H NMR: δ 4.73 (s, 1H, CH), 6.42 (s, 2H, NH2), 7.09 (dd, 1H, J = 7.50 Hz and 1.5 Hz, C11-H), 7.25 (d, 2H, J = 7.7 Hz, C3-H, C5-H of pyridine), 7.30–7.40 (m, 2H, C9-H and C10-H), 7.80 (dd, 1H, J = 7.50 Hz and 1.50 Hz, C8-H), 8.55 (d, 2H, J = 7.7 Hz, C2-H, C6-H of pyridine), 11.45 (s, 1H, NH); 13C NMR: δ 28.3, 58.9, 61.2, 102.1, 115.5, 117.6, 120.1, 121.4, 122.6, 123.5 (3C), 126.4, 136.8, 145.5, 146.7, 148.3 (2C), 162.3, 163.4, 165.4; MS: m/z 396 (M+, 100%). Anal. Calcd for C21H12N6OS (396.43): C, 63.63; H, 3.05; N, 21.20. Found: C, 63.55; H, 3.13; N, 21.28.
Acknowledgments
The authors are very grateful to Dr. A.A. Fadda, professor of Organic Chemistry, Chemistry Department, Faculty of Science, Mansoura University, for guidance, precious advice, and support.
References
[1] Gupta, S.; Ajmera, N.; Gautam, N.; Sharma, R.; Gauatam, D. Novel synthesis and biological activity study of pyrimido [2,1-b] benzothiazoles. Indian J. Chem. 2009, 48B, 853–858.Search in Google Scholar
[2] Kumbhare, R. M.; Ingle, V. N. Synthesis of novel benzothiozole and benzisoxazole functionalized unsymmetrical alkanes and study of their antimicrobial activity. Indian J. Chem.2009, 48B, 996–1000.10.1002/chin.200947101Search in Google Scholar
[3] Murthi, Y.; Pathak, D. Synthesis and Antimicrobial screening of substituted 2-mercaptobenzothiazoles. J. Pharm. Res.2008, 7, 153–155.Search in Google Scholar
[4] Rajeeva, B.; Srinivasulu, N.; Shantakumar, S. Synthesis and antimicrobial activity of some new 2-substituted benzothiazole derivatives. E-J. Chem. 2009, 6, 775–779.10.1155/2009/404596Search in Google Scholar
[5] Maharan, M.; William, S.; Ramzy, F.; Sembel, A. Synthesis and in vitro evaluation of new benzothiazolederivaties as schistosomicidal agents. Molecules2007, 12, 622–633.10.3390/12030622Search in Google Scholar PubMed PubMed Central
[6] Kini, S.; Swain, S.; Gandhi, A. M. Synthesis and evaluation of novel benzothiazole derivatives against human cervical cancer cell lines. Indian J. Pharm. Sci.2007, 69, 46–50.10.4103/0250-474X.32107Search in Google Scholar
[7] Stanton, H. L. K.; Gambari, R.; Chung, H. C.; Johny, C. O. T.; Filly, C.; Albert, S. C. C. Synthesis and anti-cancer activity of benzothiazole containing phthalimide on human carcinoma cell lines. Bioorg. Med. Chem. 2008, 16, 3626–3631.10.1016/j.bmc.2008.02.005Search in Google Scholar PubMed
[8] Wang, M.; Gao, M.; Mock, B.; Miller, K.; Sledge, G.; Hutchins, G.; Zheng, Q. Synthesis of C-11 labelled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agent. Bioorg. Med. Chem.2006, 14, 8599–8607.10.1016/j.bmc.2006.08.026Search in Google Scholar PubMed
[9] Hutchinson, I.; Chua, M. S.; Browne, H. L.; Trapani, V.; Bradshaw, T. D.; Westwell, A. D.; Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. J. Med. Chem. 2001, 44, 1446–1449.10.1021/jm001104nSearch in Google Scholar PubMed
[10] Huang, S.-T.; Hsei, I.-J.; Chen, C. Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles. Bioorg. Med. Chem.2006, 14, 6106–6119.10.1016/j.bmc.2006.05.007Search in Google Scholar PubMed
[11] Lion, C. J.; Matthews, C. S.; Wells, G.; Bradshaw, T. D.; Stevens, M. F. G.; Westwell, A. D. Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones (quinols). Bioorg. Med. Chem. Lett.2006, 16, 5005–5008.10.1016/j.bmcl.2006.07.072Search in Google Scholar PubMed
[12] Sreenivasa, M.; jaychand, E.; Shivakumar, B., Jayrajkumar, K.; Vijaykumar, J. Synthesis of bioactive molecule flurobenzothiazole comprising potent heterocylic moieties for anthelmintic activity. Arch. Pharm. Sci. and Res.2009, 1, 150–157.Search in Google Scholar
[13] Siddiqui, N.; Pandeya, S. N.; Khau, S. A.; Stables, J.; Rana, A.; Alam, M.; MdArshad, F.; Bhat, M. A. Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain. Bioorg. Med. Chem. Lett.2007, 17, 255–259.10.1016/j.bmcl.2006.09.053Search in Google Scholar PubMed
[14] Pattan, S.; Suresh, C.; Pujar, V.; Reddy, V.; Rasa, V.; Koti, B. Synthesis and antidiabetic activity of 2-amino[5′(4-sulphonylbenzylidine)-2,4- thiazolidinenone]-7-chloro-6-flurobenzothiazole. Indian J. Chem. 2005, 44B, 2404–2408.Search in Google Scholar
[15] Razus, A. C.; Birzan, L.; Surugiu, N. M.; Corbu, A. C.; Chiraleu, F. Syntheses of azulen-1-yl-benzothiazol-2-yl diazenes. Dyes Pigm.2007, 74, 26–33.10.1016/j.dyepig.2006.01.041Search in Google Scholar
[16] Bagley, M. C.; Hughes, D. D.; Lloyd, R.; Powers, V. E. C. A new and highly expedient synthesis of pyrido[2,3-d]pyrimidines. Tetrahedron Lett.2001, 42, 6585–6588.10.1016/S0040-4039(01)01297-7Search in Google Scholar
[17] Thibault, S.; Frédéric, B.; Nuno, R.; Marie-Ludivine, T.; Lionel, C.; Stéphane, B.; Pascal, B.; Gérald, G.; Mohamed, A.; Anne, C.; et al. Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitors. J. Med. Chem.2014, 57, 613–631.10.1021/jm401138vSearch in Google Scholar PubMed
[18] Buron, F.; Mérour, J. Y.; Akssira, M.; Guillaumet, G.; Routier, S. Recent advances in the chemistry and biology of pyridopyrimidines. Eur. J. Med. Chem.2015, 95, 76–95.10.1016/j.ejmech.2015.03.029Search in Google Scholar PubMed
[19] Litvinov, V. P. Chemistry and biological activities of 1,8-naphthyridines. Russ. Chem. Rev.2004, 73, 637–669.10.1070/RC2004v073n07ABEH000856Search in Google Scholar
[20] Clark, R. F.; Wang, S.; Ma, Z.; Weitzberg, M.; Motter, C.; Tufano, M.; Wagner, R.; Gu, Y.; Dandliker, P. J.; Lerner, C. G.; et al. Novel inhibitors of bacterial protein synthesis: structure–activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants. Bioorg. Med. Chem. Lett.2004, 14, 3299–3302.10.1016/j.bmcl.2004.03.091Search in Google Scholar PubMed
[21] Ponnurengam, M. S.; Geetha, I.; Mukesh, D. QSAR studies on substituted 3- or 4-phenyl-1,8-naphthyridine derivatives as antimicrobial agents. Med. Chem. Res. 2012, 21, 788–795.10.1007/s00044-011-9564-xSearch in Google Scholar
[22] Zhang, S. X.; Bastow, K. F.; Tachibana, Y.; Kuo, S. C.; Hamel, E.; Mauger, A.; Narayanan, V. L.; Lee, K. H. Antitumor agents 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity and inhibition of tubulin polymerization. J. Med. Chem. 1999, 42, 4081–4087.10.1021/jm990208zSearch in Google Scholar PubMed
[23] Ferrarini, P. L.; Mori, C.; Badawneh, M.; Franconi, F.; Manera, C.; Miceli, M.; Saccomanni, G. Synthesis and antiplatelet activity of some 3-phenyl-1,8-naphthyridine derivatives. Il Farmaco2000, 55, 603–610.10.1016/S0014-827X(00)00085-9Search in Google Scholar PubMed
[24] Ferrarini, P. L.; Badawneh, M.; Franconi, F.; Manera, C.; Miceli, M.; Mori, C.; Saccomanni, G. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives. Il Farmaco2001, 56, 311–318.10.1016/S0014-827X(01)01075-8Search in Google Scholar
[25] Reddy, P.; Lin, Y.; Chang, H. Synthesis of novel benzothiazole compounds with an extended conjugated system. Arkivoc. 2007, xvi, 113–122.10.3998/ark.5550190.0008.g12Search in Google Scholar
[26] Heo, Y.; Song, Y.; Kim, B.; Heo, J. A highly regioselective synthesis of 2-aryl-6-chlorobenzothiazoles employing microwave-promoted Suzuki-Miyaura coupling reaction. Tetrahedron Lett.2006, 47, 3091–3094.10.1016/j.tetlet.2006.02.152Search in Google Scholar
[27] Mohamed Khaled, S.; Abdulaziz Nayra, M.; Fadda Ahmed, A. Synthesis of some new pyridine and pyrimidine derivatives containing benzothiazole moiety J. Heterocycl. Chem.2013, 50, 645–649.10.1002/jhet.1672Search in Google Scholar
[28] Mohamed Khaled, S.; Abdulaziz Nayra, M.; Fadda Ahmed, A. Synthesis of new heterocyclic rings containing benzothiazole moiety. J. Heterocycl. Chem. 2013, 50, 650–653.10.1002/jhet.1685Search in Google Scholar
[29] Fadda, A. A.; Abdelrazek, F. M.; Mohamed Khaled, S.; Ghieth, H.; Etman, H. A. Synthetic applications of benzothiazole containing cyanoacetyl group Eur. J. Chem.2010, 1, 90–95.10.5155/eurjchem.1.2.90-95.32Search in Google Scholar
[30] Fadda, A. A.; Zaki, M. E. A.; Samir, KH.; Amer, F. A. Nitriles in organic synthesis: Synthesis of some new 2-heterocyclic benzothiazole derivatives. Phosphorus Sulfur Silicon Relat. Elem.2007, 182, 1845–1856.10.1080/10426500701323432Search in Google Scholar
[31] Trilleras Jorge, E.; Velasquez Kelly, J.; Pacheco Dency, J.; Quiroga, J.; Ortíz, A. Microwave-assisted synthesis under solvent-free conditions of (E)-2-(benzo[d]thiazol-2-yl)-3-arylacrylonitriles. J. Braz. Chem. Soc.2011, 22, 2396–2402.10.1590/S0103-50532011001200022Search in Google Scholar
[32] Zaki, M. E. A.; Fadda, A. A.; Samir, K.; Amer, F. A. Nitriles in organic synthesis: synthesis of pyrido[2,1-b]benzothiazole derivatives and polyfunctionally-substituted pyridines. Chem. Heterocycl. Compd.2003, 39, 1242–1248.10.1023/B:COHC.0000008274.04008.c2Search in Google Scholar
[33] Metwally, N. H.; Abdelrazek, F. M. Reaction of anthranilonitrile with some active methylene reagents: synthesis of some new quinoline and quinazoline derivatives. Synth. Commun.2005, 35, 2481–2487.10.1080/00397910500192068Search in Google Scholar
©2015 by De Gruyter
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles in the same Issue
- Frontmatter
- Preliminary Communications
- Montmorillonite K10 catalyzed multi component reactions (MCR): synthesis of novel thiazolidinones as anticancer agents
- Synthesis, antibacterial, and antifungal activities of new pyrimidinone derivatives
- Research Articles
- Formation of 1-methyl[1,2,4]triazolo[4,3-a] quinazolin-5(4H)-ones by reaction of 2-hydrazinoquinazolin-4(3H)-ones with acetylacetone
- Synthesis of new 4′-(N-alkylpyrrol-2-yl)-2,2′: 6′,2″-terpyridines via N-alkylation of a pyrrole moiety
- Efficient synthesis of 3-(bromomethyl)-5-methylpyridine hydrobromide
- One-pot synthesis of 5-[1-substituted 4-acetyl-5-methyl-1H-pyrrol-2-yl)]-8-hydroxyquinolines using DABCO as green catalyst
- A new on-fluorescent sensor for Ag+ based on benzimidazole bearing bis(ethoxycarbonylmethyl)amino groups
- Synthesis of new derivatives of 10H-benzo[b]pyridazino[3,4-e][1,4]thiazines
- Efficient and convenient synthesis of pyrido [2,1-b]benzothiazole, pyrimidopyrido[2,1-b]benzothiazole and benzothiazolo[3,2-a][1,8]naphthyridine derivatives
- Synthesis of 3-benzylidene-dihydrofurochromen-2-ones: promising intermediates for biflavonoid synthesis
- Synthesis and antitumor activities of piperazine- and cyclen-conjugated dehydroabietylamine derivatives
- Synthesis, characterization, and antimicrobial evaluation of novel spiropiperidones
Articles in the same Issue
- Frontmatter
- Preliminary Communications
- Montmorillonite K10 catalyzed multi component reactions (MCR): synthesis of novel thiazolidinones as anticancer agents
- Synthesis, antibacterial, and antifungal activities of new pyrimidinone derivatives
- Research Articles
- Formation of 1-methyl[1,2,4]triazolo[4,3-a] quinazolin-5(4H)-ones by reaction of 2-hydrazinoquinazolin-4(3H)-ones with acetylacetone
- Synthesis of new 4′-(N-alkylpyrrol-2-yl)-2,2′: 6′,2″-terpyridines via N-alkylation of a pyrrole moiety
- Efficient synthesis of 3-(bromomethyl)-5-methylpyridine hydrobromide
- One-pot synthesis of 5-[1-substituted 4-acetyl-5-methyl-1H-pyrrol-2-yl)]-8-hydroxyquinolines using DABCO as green catalyst
- A new on-fluorescent sensor for Ag+ based on benzimidazole bearing bis(ethoxycarbonylmethyl)amino groups
- Synthesis of new derivatives of 10H-benzo[b]pyridazino[3,4-e][1,4]thiazines
- Efficient and convenient synthesis of pyrido [2,1-b]benzothiazole, pyrimidopyrido[2,1-b]benzothiazole and benzothiazolo[3,2-a][1,8]naphthyridine derivatives
- Synthesis of 3-benzylidene-dihydrofurochromen-2-ones: promising intermediates for biflavonoid synthesis
- Synthesis and antitumor activities of piperazine- and cyclen-conjugated dehydroabietylamine derivatives
- Synthesis, characterization, and antimicrobial evaluation of novel spiropiperidones